Can we predict Crohn's damage before it happens? a Long-Term study aims to find out

NCT ID NCT05420233

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This study follows people newly diagnosed with Crohn's disease for up to five years to see how the condition damages the bowel over time. Researchers will use imaging scans and other tests to track disease progression and understand how different treatments affect long-term outcomes. The goal is to develop better ways to predict and prevent permanent bowel damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors predict which treatments best prevent long-term bowel damage in Crohn's disease.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly test a new therapy. Results depend on careful follow-up over many years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Algomed Policlinic

    Timișoara, Romania

  • American Gastroenterology Center

    Stróvolos, Cyprus

  • Azienda Ospedaliera di Padova

    Padova, Italy

  • CHU Amiens-Picardie Hôpital Sud

    Amiens, France

  • CHU Estaing Clermont - Ferrand

    Clermont-Ferrand, France

  • Claude Huriez Hospital, Lille University

    Lille, France

  • Hospital Alvaro Cunqueiro - Área Sanitária de Vigo

    Vigo, Spain

  • Hospital Beatriz Angelo

    Loures, Loures, Portugal

  • Hospital Clinic Barcelona

    Barcelona, Spain

  • Hospital Galdakao-Usansolo

    Galdakao, Spain

  • Hospital Garcia da Orta

    Almada, Almada, Portugal

  • Hull University Teaching Hospitals NHS Trust

    Hull, United Kingdom

  • Hvidovre Hospital

    Hvidovre, Denmark

  • IBD Clinical and Research Clinic, ISCARE

    Prague, Czechia

  • Instituto Portugues de Oncologia de Lisboa

    Lisbon, Lisbon District, Portugal

  • Mater dei hospital

    Msida, Malta

  • Slagelse Hospital

    Slagelse, Denmark

  • St Mark's Hospital

    London, United Kingdom

  • University Hospital CHU of Liège

    Liège, Liège, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.